Outcomes Following Delta Xtend Reverse Shoulder System

• Conditions: Reverse Total Shoulder Arthroplasty
• Interventions: Device: DePuy Delta Xtend Reverse TSA

• Registration Number: NCT02014350
• Lead Sponsor: Rothman Institute Orthopaedics

Brief Summary

To collect medium to long-term survivorship implant outcomes on the DePuy Delta Xtend Reverse Shoulder Stystem.

Detailed Description

Not available

Study Timeline

• Status Verified: 2013-12
• Study First Submitted: 2013-12-12
• Study First Submitted QC: 2013-12-17
• Last Update Submitted: 2013-12-17
• Study First Posted: 2013-12-18
• Last Update Posted: 2013-12-18
• Primary Completion: 2020-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Patients whom were implanted with the DePuy Delta Xtend Reverse Total Shoulder System in the time frame indicated. Patients must be willing to sign the consent form and complete all follow-up visits.

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
DePuy Delta Xtend RTSA	DePuy Delta Xtend Reverse TSA	-

Primary Outcome Measures

Name	Time	Method
Implant Survivorship	10 years post-operative

Trial Locations

Locations (1)

Rothman Institute; 🇺🇸 Philadelphia, Pennsylvania, United States